Cargando…
Systematic characterization of the tumor microenvironment in Chinese patients with hepatocellular carcinoma highlights intratumoral B cells as a potential immunotherapy target
Hepatocellular carcinoma (HCC) is an immunogenic malignancy, which exhibits low responsiveness to programmed cell death protein-1 (PD-1)/programmed death ligand-1 (PD-L1) antibodies. Therefore, the identification of novel immunotherapeutic targets to treat HCC is imperative. Systematic characterizat...
Autores principales: | Feng, Yu, Liu, Liguo, Li, Jing, Huang, Jia, Xie, Jenny H., Menard, Laurence, Shi, Yanfen, Zhao, Xiaohong, Xie, Shan, Zang, Wenjuan, Tan, Haidong, Yang, Zhiying, Ni, Ling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8717124/ https://www.ncbi.nlm.nih.gov/pubmed/34958112 http://dx.doi.org/10.3892/or.2021.8249 |
Ejemplares similares
-
Addressing the Adult Soft Tissue Sarcoma Microenvironment with Intratumoral Immunotherapy
por: Raj, Shailaja, et al.
Publicado: (2018) -
The modulation relationship of genomic pattern of intratumor heterogeneity and immunity microenvironment heterogeneity in hepatocellular carcinoma
por: Li, Liu-Bo, et al.
Publicado: (2020) -
Immunotherapeutic Agents for Intratumoral Immunotherapy
por: Shyr, Chih-Rong, et al.
Publicado: (2023) -
Influence of injection technique, drug formulation and tumor microenvironment on intratumoral immunotherapy delivery and efficacy
por: Muñoz, Nina M., et al.
Publicado: (2021) -
Intratumoral Immunotherapy—Update 2019
por: Hamid, Omid, et al.
Publicado: (2019)